|
US5871728A
(en)
|
1995-03-31 |
1999-02-16 |
University Of Pittsburgh |
Method of regulating dendritic cell maturation
|
|
US6006752A
(en)
*
|
1996-05-09 |
1999-12-28 |
The General Hospital Corporation |
Mixed chimerism and tolerance
|
|
DE69841058D1
(de)
|
1997-11-14 |
2009-09-24 |
Gen Hospital Corp |
Behandlung von hämatologischen störungen
|
|
IL137614A0
(en)
|
1998-02-04 |
2001-07-24 |
Gen Hospital Corp |
An inhibitor of a costimulatory pathway and hematopoietic stem cells for promoting graft acceptance
|
|
WO1999047163A2
(en)
*
|
1998-03-18 |
1999-09-23 |
Osiris Therapeutics, Inc. |
Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
|
|
WO2000011147A1
(en)
*
|
1998-08-20 |
2000-03-02 |
The General Hospital Corporation |
Inbred mhc-homozygous miniature swine and uses thereof
|
|
WO2000045842A2
(en)
*
|
1999-02-04 |
2000-08-10 |
The General Hospital Corporation |
Methods for human allografting
|
|
WO2000054786A1
(en)
*
|
1999-03-15 |
2000-09-21 |
Modex Therapeutiques, S.A. |
Methods and compositions for tolerizing hosts for long term survival of tissue transplants
|
|
US6750023B2
(en)
*
|
1999-09-02 |
2004-06-15 |
Corning Incorporated |
Porous inorganic substrate for high-density arrays
|
|
US20010046489A1
(en)
*
|
1999-12-06 |
2001-11-29 |
Habener Joel E. |
Stem cells of the islets of langerhans and their use in treating diabetes mellitus
|
|
EP1250594A4
(en)
*
|
2000-01-19 |
2003-05-07 |
Biotransplant Inc |
PORC UNABLE TO TRANSMIT PORCINE ENDOGENEOUS RETROVIRUS, AND USES THEREOF
|
|
AU3929402A
(en)
*
|
2000-11-22 |
2002-06-11 |
Geron Corp |
Tolerizing allografts of pluripotent stem cells
|
|
WO2002074938A1
(en)
*
|
2001-03-20 |
2002-09-26 |
Trustees Of Amherst College |
Methods for producing antibodies in mammals
|
|
US20030044398A1
(en)
*
|
2001-03-20 |
2003-03-06 |
Robl James M. |
Methods for producing antibodies in mammals
|
|
US20020152490A1
(en)
*
|
2001-04-12 |
2002-10-17 |
Philip Lake |
Tolerance-inducing thy-marrow composite tissue construct and organ
|
|
US20030031652A1
(en)
*
|
2001-04-16 |
2003-02-13 |
Bernhard Hering |
Systems and methods for inducing mixed chimerism
|
|
US20030032631A1
(en)
*
|
2001-08-13 |
2003-02-13 |
Mcdonald George B. |
Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
|
|
US20050058641A1
(en)
*
|
2002-05-22 |
2005-03-17 |
Siemionow Maria Z. |
Tolerance induction and maintenance in hematopoietic stem cell allografts
|
|
EP1549277A4
(en)
*
|
2002-05-22 |
2007-09-05 |
Cleveland Clinic Foundation |
INDUCING AND MAINTAINING COMPLEX TISSUE ALLOGRAFT TOLERANCE
|
|
WO2005021734A2
(en)
*
|
2003-09-02 |
2005-03-10 |
University Of Massachussets |
Generation of hematopoietic chimerism and induction of central tolerance
|
|
US20050266001A1
(en)
*
|
2004-04-02 |
2005-12-01 |
Hadley Gregg A |
Therapeutic blockade of CD103 interactions to prevent clinical renal allograft rejection
|
|
US20060147429A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Facilitated cellular reconstitution of organs and tissues
|
|
US20060148080A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Methods for supporting and producing human cells and tissues in non-human mammal hosts
|
|
WO2007033221A2
(en)
*
|
2005-09-13 |
2007-03-22 |
The General Hospital Corporation |
Methods and compositions for inhibition of immune responses
|
|
JP2010503710A
(ja)
|
2006-09-18 |
2010-02-04 |
ラプトール ファーマシューティカル インコーポレイテッド |
受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
|
|
EP2607477B1
(en)
|
2007-05-03 |
2020-09-23 |
The Brigham and Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
|
US8574567B2
(en)
*
|
2007-05-03 |
2013-11-05 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
|
CN113476478A
(zh)
|
2013-02-26 |
2021-10-08 |
小利兰·斯坦福大学托管委员会 |
实现移植物移植耐受的联合器官和造血细胞
|
|
CA2907915C
(en)
|
2013-04-03 |
2023-03-07 |
Allertein Therapeutics, Llc |
Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
|
|
GB201413240D0
(en)
*
|
2014-07-25 |
2014-09-10 |
Hansa Medical Ab |
Method
|
|
CN116732106A
(zh)
|
2017-04-20 |
2023-09-12 |
E开创生物技术股份有限公司 |
产生基因修改的动物的方法
|
|
EP3765044A4
(en)
|
2018-03-12 |
2021-12-08 |
Medeor Therapeutics, Inc. |
TREATMENT METHODS FOR NON-CANCERIOUS DISORDERS USING HEMATOPOIETIC CELLS
|
|
US10881692B2
(en)
|
2018-04-05 |
2021-01-05 |
Medeor Therapeutics, Inc. |
Compositions for establishing mixed chimerism and methods of manufacture thereof
|
|
US10842821B2
(en)
|
2018-04-05 |
2020-11-24 |
Medeor Therapeutics, Inc. |
Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
|
|
US11435350B2
(en)
|
2018-09-18 |
2022-09-06 |
Medeor Therapeutics, Inc. |
Methods of analysis of blood from deceased donors
|
|
US11813376B2
(en)
|
2018-09-18 |
2023-11-14 |
Medeor Therapeutics, Inc. |
Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof
|
|
IL302830A
(en)
|
2020-11-13 |
2023-07-01 |
Egenesis Inc |
Cells, tissues, organs and animals with one or more genes that have been modified for improved survival and tolerance of a different-sex transplant
|